BORDER BIOMEDICAL RESEARCH CENTER: ADMINISTRATION

边境生物医学研究中心：行政

• 批准号: 8166182
• 负责人: Diana S. Natalicio
• 金额: $ 61.44万
• 依托单位: UNIVERSITY OF TEXAS EL PASO
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-07-01 至 2011-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8166182
• 关键词: Area; Bioinformatics; Biological Sciences; Biology; Biomedical Research; Cell Culture Techniques; Chemistry; Collaborations; Computer Retrieval of Information on Scientific Projects Database; Consult; Cytology; DNA analysis; Disease; Doctor of Philosophy; Faculty; Funding; Goals; Grant; Health Sciences; Health education; Hispanics; Housing; Infectious Disease Immunology; Institution; International; Laboratories; Mainstreaming; Medical; Mexico; Neurosciences; Pathology; Physics; Population; Productivity; Psychology; Research; Research Infrastructure; Research Personnel; Research Priority; Research Training; Resources; Source; Talents; Texas; Toxicology; Translational Research; Underrepresented Minority; United States; United States National Institutes of Health; Universities; college; high throughput screening; post-doctoral training; programs; research facility

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The University of Texas at El Paso (UTEP) proposes to enhance basic and translational research on pathologies prevalent in the Hispanic-majority population along the United States border with Mexico. Specifically, UTEP seeks to increase the productivity and capacity of its Border Biomedical Research Center (BBRC) to promote new discoveries and apply them to benefit health and education in this region and the nation as a whole. To accomplish this, the institution has assigned priority for research in (1) infectious diseases and immunology, (2) toxicology, and (3) neuroscience and metaboilic disorders, major research thrusts of the BBRC. The BBRC's research team has been expanded with faculty acquisitions in Biological Sciences, Chemistry, Physics, Psychology, and the College of Health Sciences. Commitments of support have been obtained from external research centers, such as the national laboratories at the University of Texas Medical Branch in Galveston. A new Biosciences research facility has been built on campus, and houses BBRC Core labs in Cell Culture and High Throughput Screening , DNA Analysis, Analytical Cytology, Biomolecule Analysis, Bioinformatics and Statistical Consulting. These Core resources are being used to attract additional talent that will contribute to the biomedical research program. The developing scientific competitiveness of BBRC investigators is evident in the increased number of R-O1 grants funded, from 0 to 6, in the last three years alone. The BBRC provides a strong research infrastructure for undergraduate, graduate and postdoctoral training. Thus, through this key RCMI-supported program UTEP is realizing an institutional goal of serving as a major point of entry for underrepresented minorities into the biomedical research mainstream of the nation. As partial evidence of progress in this area, UTEP has increased its Ph.D. graduates in biology from 0 to 14 in this past RCMI funding cycle. Through significant RCMI support and a strong institutional commitment to the BBRC, and through the productivity and collaborations of this Center, UTEP is establishing itself as a leading regional research entity and is gaining national and international recognition for its biomedical research and training resources and capabilities.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 德克萨斯大学埃尔帕索分校（UTEP）建议加强对沿着美国与墨西哥边境的西班牙裔人口中流行的病理学的基础和转化研究。具体而言，UTEP旨在提高其边境生物医学研究中心（BBRC）的生产力和能力，以促进新发现并将其应用于该地区乃至整个国家的健康和教育。为了实现这一目标，该机构已指定优先研究（1）传染病和免疫学，（2）毒理学，（3）神经科学和代谢紊乱，BBRC的主要研究方向。BBRC的研究团队已经扩大了生物科学，化学，物理学，心理学和健康科学学院的教师收购。已经从外部研究中心获得了支持的承诺，例如位于加尔维斯顿的德克萨斯大学医学分支的国家实验室。一个新的生物科学研究设施已在校园内建成，并在细胞培养和高通量筛选，DNA分析，分析细胞学，生物分子分析，生物信息学和统计咨询方面拥有BBRC核心实验室。这些核心资源被用来吸引更多的人才，将有助于生物医学研究计划。仅在过去三年中，BBRC研究人员的科学竞争力不断发展，R-O 1赠款资助的数量从0增加到6。BBRC为本科生，研究生和博士后培训提供了强大的研究基础设施。因此，通过RCMI支持的这一关键计划，UTEP正在实现一个机构目标，即作为代表性不足的少数民族进入国家生物医学研究主流的主要入口点。作为在这一领域取得进展的部分证据，UTEP增加了其博士学位。在过去的RCMI资助周期中，从0到14岁的生物学毕业生。通过RCMI的大力支持和对BBRC的强有力的机构承诺，并通过该中心的生产力和合作，UTEP正在建立自己作为一个领先的区域研究实体，并获得其生物医学研究和培训资源和能力的国家和国际认可。